Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC).

(2017) E. A. Quoix et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy

(2010) Maciej Krzakowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLC

(2010) Tomoya Kawaguchi et al.   Journal of Thoracic Oncology

Health-related quality of life in patients surviving non-small cell lung cancer

(2010) J. P. C. Grutters et al.   THORAX

Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice

(2009) D. Tassinari et al.   ANNALS OF ONCOLOGY

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population

(2009) A. G. Pallis et al.   ANNALS OF ONCOLOGY

Second-Line Treatments in Non-small Cell Lung Cancer

(2009) Davide Tassinari et al.   CHEST

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

(2009) Bjørn H. Grønberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Adverse Events Among the Elderly Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer

(2009) Elizabeth A. Chrischilles et al.   JOURNAL OF CLINICAL ONCOLOGY

The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

(2009) G. Scagliotti et al.   ONCOLOGIST

Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer

(2009) Young Hak Kim et al.   RESPIRATORY MEDICINE

Improving Health-Related Quality of Life in Non–Small-Cell Lung Cancer with Current Treatment Options

(2008) David F. Cella et al.   Clinical Lung Cancer

Efficacy and safety of pemetrexed in elderly cancer patients: Results of an integrated analysis

(2008) Pandurang M. Kulkarni et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer?

(2008) Esther Dajczman et al.   Journal of Thoracic Oncology

Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research

(2008) Rogerio C. Lilenbaum et al.   Journal of Thoracic Oncology